Form 4: Mesa Laboratories Director Jennifer Alltoft Reports Stock Transaction
SEC Form 4 Filing
Director Jennifer Alltoft reports the vesting and disposal of Restricted Stock Units (RSUs) into common stock of Mesa Laboratories on September 1, 2024.
Summary
- On September 1, 2024, Jennifer Alltoft, a director of Mesa Laboratories Inc., reported a transaction involving Restricted Stock Units (RSUs).
- The transaction involved the vesting of 1,074 RSUs, which converted into 1,074 shares of common stock.
- Following the transaction, Ms. Alltoft directly owns 3,474 shares of Mesa Laboratories Inc. common stock.
- The vesting of the RSUs was a non-cash transaction, with a price of $0.
Sentiment
Score: 5
Explanation: This is a routine disclosure of an insider transaction, neither inherently positive nor negative.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.
Stakeholder Impact
- The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares from vested RSUs.
Key Dates
| Date | Description |
|---|---|
| 09/01/2024 | Date of transaction: vesting of Restricted Stock Units and conversion to common stock. |
| 09/06/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.